Details of the Drug Reposition

General Information of This Drug (ID: DMB7JS4)

Drug Name
Anti-CD19 CAR-T cell therapy   DMB7JS4

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)
3 Phase 1 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Lymphoma DISN6V4S 2A80-2A86 Phase 1 [1]
B-cell lymphoma DISIH1YQ 2A86 Phase 1 [2]
Haematological malignancy DISCDP7W 2B33.Y Phase 1 [2]
------------------------------------------------------------------------------------

References

1 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
2 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)